Perrigo (PRGO) to Release Earnings on Wednesday

Perrigo (NYSE:PRGO - Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 7th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $1.09 billion for the quarter.

Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The firm had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.20 billion. On average, analysts expect Perrigo to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Perrigo Stock Up 1.5 %

PRGO stock traded up $0.38 during mid-day trading on Friday, hitting $25.65. The stock had a trading volume of 888,624 shares, compared to its average volume of 1,520,769. The stock has a market capitalization of $3.50 billion, a price-to-earnings ratio of -21.92 and a beta of 0.49. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. Perrigo has a 1-year low of $23.14 and a 1-year high of $33.46. The company has a fifty day moving average of $26.56 and a 200 day moving average of $26.09.

Perrigo Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be given a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 4.52%. The ex-dividend date is Friday, May 30th. Perrigo's payout ratio is presently -92.80%.

Insiders Place Their Bets

In other news, EVP Ronald Craig Janish sold 7,800 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the transaction, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. The trade was a 18.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Piper Sandler lowered shares of Perrigo from an "overweight" rating to a "neutral" rating and dropped their price target for the stock from $34.00 to $27.00 in a research note on Monday, January 6th. StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Finally, Argus downgraded Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $33.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.